Point6 Bio

Point6 Bio
Developing novel therapeutics for age-related diseases using senolytic compounds.
About
What does Point6 Bio do?
Point6 Bio is a biotechnology company focused on developing innovative treatments for age-related diseases. They are specifically targeting cellular senescence, a key driver of aging and numerous chronic conditions, by developing senolytic compounds that selectively clear senescent cells.
Where is Point6 Bio headquartered?
Point6 Bio is headquartered in Cambridge, United States.
When was Point6 Bio founded?
Point6 Bio was founded in 2021.
What industry does Point6 Bio operate in?
Point6 Bio operates in Biotech, MedTech, HealthTech, Drug Discovery, Longevity, Senolytics.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
Discover innovative AI therapeutics at fibrotherapeutics.ai, enhancing patient care and advancing health technology.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.